AIM
BMY icon

Advantage Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Advantage Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$143K Buy
2,819
+1,800
+177% +$84.6K 0.11% 180
2019
Q2 		$46K Hold
1,019
– – 0.04% 358
2019
Q1 		$49K Buy
1,019
+86
+9% +$4.28K 0.04% 349
2018
Q4 		$49K Sell
933
-4
-0.4% -$215 0.04% 345
2018
Q3 		$58K Sell
937
-1,460
-61% -$86.6K 0.04% 363
2018
Q2 		$133K Sell
2,397
-13,933
-85% -$752K 0.1% 178
2018
Q1 		$1.03M Sell
16,330
-350
-2% -$22.5K 0.39% 53
2017
Q4 		$1.02M Buy
16,680
+223
+1% +$13.9K 0.32% 69
2017
Q3 		$1.05M Sell
16,457
-35,244
-68% -$2.06M 0.34% 66
2017
Q2 		$2.88M Buy
51,701
+1,601
+3% +$87.1K 1.01% 26
2017
Q1 		$2.72M Buy
50,100
+3,769
+8% +$207K 1.08% 23
2016
Q4 		$2.71M Buy
46,331
+45,641
+6,615% +$2.5M 1% 29
2016
Q3 		$37K Buy
690
+523
+313% +$33.6K 0.01% 388
2016
Q2 		$12K Hold
167
– – 0.01% 553
2016
Q1 		$11K Sell
167
-160
-49% -$10.1K ﹤0.01% 543
2015
Q4 		$22K Buy
327
+160
+96% +$10.6K 0.01% 445
2015
Q3 		$10K Hold
167
– – 0.01% 535
2015
Q2 		$11K Sell
167
-45
-21% -$2.97K 0.01% 563
2015
Q1 		$14K Sell
212
-25
-11% -$1.56K 0.01% 525
2014
Q4 		$14K Buy
+237
New +$13.4K 0.01% 466

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advantage Investment Management's BMY Position: Q3 2019 in Review

Advantage Investment Management increased its Bristol-Myers Squibb (BMY) stake by 177% in Q3 2019, buying an estimated $84.6K and bringing the position to 2,819 shares worth $143K. The position accounts for 0.11% of the portfolio, ranked #180.

Advantage Investment Management first reported a position in BMY in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.88M in Q2 2017. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Advantage Investment Management held 2,819 shares of Bristol-Myers Squibb worth $143K as of Q3 2019.
  • Advantage Investment Management bought 1,800 Bristol-Myers Squibb shares in Q3 2019, an estimated $84.6K.
  • Bristol-Myers Squibb made up 0.11% of Advantage Investment Management's portfolio in Q3 2019, its #180 holding.
  • Advantage Investment Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Bristol-Myers Squibb position peaked at $2.88M in Q2 2017.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.